Muhammad Rajaei Ahmad

Dr. Muhammad Rajaei Ahmad

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
KBKaushik Kumar Bharadwaj
Kaushik Kumar Bharadwaj
IAIqrar Ahmad
Iqrar Ahmad
SPSiddhartha Pati
Siddhartha Pati
AGArabinda Ghosh
Arabinda Ghosh
TSTanmay Sarkar
Tanmay Sarkar
Wan Ishak Wan RosliWan Ishak Wan Rosli
Wan Ishak Wan Rosli
The seaweed industries generate considerable amounts of waste that must be appropriately managed. This biomass from marine waste is a rich source of high-value bioactive compounds. Thus, this waste can be adequately utilized by recovering the compounds for therapeutic purposes. Histone deacetylases (HDACs) are key epigenetic regulators established as one of the most promising targets for cancer chemotherapy. In the present study, our objective is to find the HDAC 2 inhibitor. We performed top-down in silico methodologies to identify potential HDAC 2 inhibitors by screening compounds from edible seaweed waste. One hundred ninety-three (n = 193) compounds from edible seaweeds were initially screened and filtered with drug-likeness properties using SwissADME. After that, the filtered compounds were followed to further evaluate their binding potential with HDAC 2 protein by using Glide high throughput virtual screening (HTVS), standard precision (SP), extra precision (XP), and quantum polarized ligand docking (QPLD). One compound with higher negative binding energy was selected, and to validate the binding mode and stability of the complex, molecular dynamics (MD) simulations using Desmond were performed. The complex-binding free energy calculation was performed using molecular mechanics-generalized born surface area (MM-GBSA) calculation. Post-MD simulation analyses such as PCA, DCCM, and free energy landscape were also evaluated. The quantum mechanical and electronic properties of the potential bioactive compounds were assessed using the density functional theory (DFT) study. These findings support the use of marine resources like edible seaweed waste for cancer drug development by using its bioactive compounds. The obtained results encourage further in vitro and in vivo research. Our in silico findings show that the compound has a high binding affinity for the catalytic site of the HDAC 2 protein and has drug-likeness properties, and can be utilized in drug development against cancer.

3 October 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
DLDibyajit Lahiri
Dibyajit Lahiri
RRRina Rani Ray
Rina Rani Ray
TSTanmay Sarkar
Tanmay Sarkar
VUVijay Jagdish Upadhye
Vijay Jagdish Upadhye
SGSujay Ghosh
Sujay Ghosh
MAMuhammad Rajaei Ahmad
Muhammad Rajaei Ahmad
The development of biofilm on the biotic and abiotic surfaces is the greatest challenge for health care sectors. At present times, oral infection is a common concern among people with an unhealthy lifestyle and most of these biofilms-associated infections are resistant to antibiotics. This has increased a search for the development of alternate therapeutics for eradicating biofilm-associated infection. Nanobiotechnology being an effective way to combat such oral infections may encourage the use of herbal compounds, such as bio-reducing and capping agents. Green-synthesis of ZnO nanoparticles (ZnO NP) by the use of the floral extract of Clitoria ternatea, a traditionally used medicinal plant, showed stability for a longer period of time. The NPs as depicted by the TEM image with a size of 10 nm showed excitation spectra at 360 nm and were found to remain stable for a considerable period of time. It was observed that the NPs were effective in the eradication of the oral biofilm formed by the major tooth attacking bacterial strains namely Porphyromonsas gingivalis and Alcaligenes faecalis, by bringing a considerable reduction in the extracellular polymeric substances (EPS). It was observed that the viability of the Porphyromonsas gingivalis and Alcaligenes faecalis was reduced by NP treatment to 87.89 ± 0.25% in comparison to that of amoxicillin. The results went in agreement with the findings of modeling performed by the use of response surface methodology (RSM) and artificial neural network (ANN). The microscopic studies and FT-IR analysis revealed that there was a considerable reduction in the biofilm after NP treatment. The in silico studies further confirmed that the ZnO NPs showed considerable interactions with the biofilm-forming proteins. Hence, this study showed that ZnO NPs derived from Clitoria ternatea can be used as an effective alternative therapeutic for the treatment of biofilm associated oral infection.

25 February 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SMSuhasini Mallick
Suhasini Mallick
MNMoupriya Nag
Moupriya Nag
DLDibyajit Lahiri
Dibyajit Lahiri
Soumya PanditSoumya Pandit
Soumya Pandit
TSTanmay Sarkar
Tanmay Sarkar
RRRina Rani Ray
Rina Rani Ray
The healing of chronic wound infections, especially cutaneous wounds, involves a complex cascade of events demanding mutual interaction between immunity and other natural host processes. Wound infections are caused by the consortia of microbial species that keep on proliferating and produce various types of virulence factors that cause the development of chronic infections. The mono- or polymicrobial nature of surface wound infections is best characterized by its ability to form biofilm that renders antimicrobial resistance to commonly administered drugs due to poor biofilm matrix permeability. With an increasing incidence of chronic wound biofilm infections, there is an urgent need for non-conventional antimicrobial approaches, such as developing nanomaterials that have intrinsic antimicrobial-antibiofilm properties modulating the biochemical or biophysical parameters in the wound microenvironment in order to cause disruption and removal of biofilms, such as designing nanomaterials as efficient drug-delivery vehicles carrying antibiotics, bioactive compounds, growth factor antioxidants or stem cells reaching the infection sites and having a distinct mechanism of action in comparison to antibiotics—functionalized nanoparticles (NPs) for better incursion through the biofilm matrix. NPs are thought to act by modulating the microbial colonization and biofilm formation in wounds due to their differential particle size, shape, surface charge and composition through alterations in bacterial cell membrane composition, as well as their conductivity, loss of respiratory activity, generation of reactive oxygen species (ROS), nitrosation of cysteines of proteins, lipid peroxidation, DNA unwinding and modulation of metabolic pathways. For the treatment of chronic wounds, extensive research is ongoing to explore a variety of nanoplatforms, including metallic and nonmetallic NPs, nanofibers and self-accumulating nanocarriers. As the use of the magnetic nanoparticle (MNP)-entrenched pre-designed hydrogel sheet (MPS) is found to enhance wound healing, the bio-nanocomposites consisting of bacterial cellulose and magnetic nanoparticles (magnetite) are now successfully used for the healing of chronic wounds. With the objective of precise targeting, some kinds of “intelligent” nanoparticles are constructed to react according to the required environment, which are later incorporated in the dressings, so that the wound can be treated with nano-impregnated dressing material in situ. For the effective healing of skin wounds, high-expressing, transiently modified stem cells, controlled by nano 3D architectures, have been developed to encourage angiogenesis and tissue regeneration. In order to overcome the challenge of time and dose constraints during drug administration, the approach of combinatorial nano therapy is adopted, whereby AI will help to exploit the full potential of nanomedicine to treat chronic wounds.

22 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
NNNur Azira Mohd Noor
Nur Azira Mohd Noor
asma abdullah nurulasma abdullah nurul
asma abdullah nurul
MAMuhammad Rajaei Ahmad
Muhammad Rajaei Ahmad
WAWan Khairunnisaa Wan Nor Aduni
Wan Khairunnisaa Wan Nor Aduni
MARYAM AZLANMARYAM AZLAN
MARYAM AZLAN
Osteoarthritis (OA) is a chronic degenerative disorder of the joint and its prevalence and severity is increasing owing to ageing of the population. Osteoarthritis is characterized by the degradation of articular cartilage and remodeling of the underlying bone. There is little understanding of the cellular and molecular processes involved in pathophysiology of OA. Currently the treatment for OA is limited to painkillers and anti-inflammatory drugs, which only treat the symptoms. Some patients may also undergo surgical procedures to replace the damaged joints. Extracellular vesicles (EV) play an important role in intercellular communications and their concentration is elevated in the joints of OA patients, although their mechanism is unclear. Extracellular vesicles are naturally released by cells and they carry their origin cell information to be delivered to target cells. On the other hand, mesenchymal stem cells (MSCs) are highly proliferative and have a great potential in cartilage regeneration. In this review, we provide an overview of the current OA treatments and their limitations. We also discuss the role of EV in OA pathophysiology. Finally, we highlight the therapeutic potential of MSC-derived EV in OA and their challenges.

22 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
FAFerid Abdulhafiz
Ferid Abdulhafiz
MRMohd Farhan Hanif Reduan
Mohd Farhan Hanif Reduan
AHAnwar Hazim Hisam
Anwar Hazim Hisam
IMIbtihal Mohammad
Ibtihal Mohammad
IWIkarastika Rahayu Abdul Wahab
Ikarastika Rahayu Abdul Wahab
MAMuhammad Rajaei Ahmad
Muhammad Rajaei Ahmad
Background:Beka (Oroxylum indicum(L.) Kurz) has been used as a culinary herb and natural remedy by the local communities in Malaysia. The leaf ofO. indicumis traditionally used for the treatment of diarrhea, high blood pressure, and improving digestive health.Objectives:The present study was conducted to evaluate the phytochemical constituents and wound healing properties (in vitroandin vivomodels) of aqueous and ethanol extracts ofO. indicumleaves.Methods:The total phenolic (TPC) and total flavonoid (TFC) contents in the plant extracts were determined by the spectrophotometric methods. Further, the extract was characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry (LC-TOF-MS/MS) and Gas Chromatography-Mass Spectrometry (GC-MS). The wound healing activity was assessed using thein vitroscratch wound-healing assay andin vivoexcisional wound model.Results:The results show the ethanol leaves extract had the higher TPC (164 mg GAE/g) when compared with the aqueous leaves extract (30 mg gallic acid equivalents/g). The ethanol leaves extract was also found to have higher TFC (101 mg Catechin equivalents/g) than the aqueous leaves extract (76 mg Catechin equivalents/g). The ethanol leaves extract was then used for further chemical analysis. The LC–TOF-MS/MS analysis showed that the leaves extracts ofO. indicumcontains many important compounds such as Orientin, Chrysin, Pinoquercetin, Cupressuflavone, Puerarin xyloside, Forsythiaside and Paederoside. In GC-MS analysis, 19 compounds were identified in ethanolic leaves extract. The wound healing studies shows thatO. indicumhas promising wound healing activity by increasing the rate of wound contraction significantly (p< 0.05).Conclusion:In conclusion, the present study showed thatO. indicumleaf contains important phytochemicals and the wound healing potential of theO. indicumextract may probably be as a result of the presence of various phytoconstituents.

7 July 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
asma abdullah nurulasma abdullah nurul
asma abdullah nurul
MARYAM AZLANMARYAM AZLAN
MARYAM AZLAN
MAMuhammad Rajaei Ahmad
Muhammad Rajaei Ahmad
ASAlphy Alphonsa Sebastian
Alphy Alphonsa Sebastian
YFYing Zhen Fan
Ying Zhen Fan
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Osteoarthritis (OA) has traditionally been known as a “wear and tear” disease, which is mainly characterized by the degradation of articular cartilage and changes in the subchondral bone. Despite the fact that OA is often thought of as a degenerative disease, the catabolic products of the cartilage matrix often promote inflammation by activating immune cells. Current OA treatment focuses on symptomatic treatment, with a primary focus on pain management, which does not promote cartilage regeneration or attenuate joint inflammation. Since articular cartilage have no ability to regenerate, thus regeneration of the tissue is one of the key targets of modern treatments for OA. Cell-based therapies are among the new therapeutic strategies for OA. Mesenchymal stem cells (MSCs) have been extensively researched as potential therapeutic agents in cell-based therapy of OA due to their ability to differentiate into chondrocytes and their immunomodulatory properties that can facilitate cartilage repair and regeneration. In this review, we emphasized current knowledge and future perspectives on the use of MSCs by targeting their regeneration potential and immunomodulatory effects in the treatment of OA.